Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 17;366(20):1891-904.
doi: 10.1056/NEJMoa1112010.

Association of coffee drinking with total and cause-specific mortality

Neal D Freedman  1 , Yikyung Park, Christian C Abnet, Albert R Hollenbeck, Rashmi Sinha
Affiliations

Association of coffee drinking with total and cause-specific mortality

Neal D Freedman et al. N Engl J Med. .

Erratum in

  • N Engl J Med. 2012 Jul 19;367(3):285

Abstract

Background: Coffee is one of the most widely consumed beverages, but the association between coffee consumption and the risk of death remains unclear.

Methods: We examined the association of coffee drinking with subsequent total and cause-specific mortality among 229,119 men and 173,141 women in the National Institutes of Health-AARP Diet and Health Study who were 50 to 71 years of age at baseline. Participants with cancer, heart disease, and stroke were excluded. Coffee consumption was assessed once at baseline.

Results: During 5,148,760 person-years of follow-up between 1995 and 2008, a total of 33,731 men and 18,784 women died. In age-adjusted models, the risk of death was increased among coffee drinkers. However, coffee drinkers were also more likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders, there was a significant inverse association between coffee consumption and mortality. Adjusted hazard ratios for death among men who drank coffee as compared with those who did not were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for drinking less than 1 cup per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups of coffee per day (P<0.001 for trend); the respective hazard ratios among women were 1.01 (95% CI, 0.96 to 1.07), 0.95 (95% CI, 0.90 to 1.01), 0.87 (95% CI, 0.83 to 0.92), 0.84 (95% CI, 0.79 to 0.90), and 0.85 (95% CI, 0.78 to 0.93) (P<0.001 for trend). Inverse associations were observed for deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections, but not for deaths due to cancer. Results were similar in subgroups, including persons who had never smoked and persons who reported very good to excellent health at baseline.

Conclusions: In this large prospective study, coffee consumption was inversely associated with total and cause-specific mortality. Whether this was a causal or associational finding cannot be determined from our data. (Funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.).

PubMed Disclaimer

Figures

Figure 1
Figure 1. Subgroup Analysis of Associations between the Consumption of 4 or More Cups of Coffee per Day and Total and Cause-Specific Mortality
Hazard ratios for death from all causes and from specific causes are for the comparison of men and women who drank 4 or more cups of coffee per day with those who did not drink coffee. Participants were classified as drinking caffeinated or decaffeinated coffee according to whether they reported drinking caffeinated or decaffeinated coffee more than half the time. Risk estimates for other categories of coffee consumption are shown in Tables 2 and 3 in the Supplementary Appendix. Risk estimates were adjusted for the following factors at baseline: age; body-mass index; race or ethnic group; level of education; alcohol consumption; the number of cigarettes smoked per day, use or non-use of pipes or cigars, and time of smoking cessation (<1 year, 1 to <5 years, 5 to <10 years, or ≥10 years before baseline); health status; diabetes (yes vs. no); marital status; physical activity; total energy intake; consumption of fruits, vegetables, red meat, white meat, and saturated fat; and use or nonuse of vitamin supplements. In addition, risk estimates for death from cancer were adjusted for history of cancer (other than nonmelanoma skin cancer) in a first-degree relative (yes vs. no). In women, risk estimates were also adjusted for use or nonuse of postmenopausal hormone therapy. Horizontal lines represent 95% confidence intervals.
Figure 2
Figure 2. Subgroup Analysis of Associations between the Consumption of 4 or More Cups of Coffee per Day and Total Mortality
Hazard ratios for death from any cause are for the comparison of men and women who drank 4 or more cups of coffee per day with those who did not drink coffee. The multivariate model was adjusted for the following factors at baseline: age; body-mass index (BMI; the weight in kilograms divided by the square of the height in meters); race or ethnic group; level of education; alcohol consumption; the number of cigarettes smoked per day, use or nonuse of pipes or cigars, and time of smoking cessation (<1 year, 1 to <5 years, 5 to <10 years, or ≥10 years before baseline); health status; diabetes (yes vs. no); marital status; physical activity; total energy intake; consumption of fruits, vegetables, red meat, white meat, and saturated fat; use or nonuse of vitamin supplements; and, in women, use or non-use of postmenopausal hormone therapy. Risk estimates for other categories of coffee consumption are shown in Tables 4 and 5 in the Supplementary Appendix. High and low dietary-intake categories are split at the median. Horizontal lines represent 95% confidence intervals. P values for interactions were computed with the use of likelihood-ratio tests comparing Cox proportional-hazards models with and without cross-product terms for each level of baseline stratifying variables, with coffee consumption as an ordinal variable. P values for the years of follow-up were derived from testing the addition of a cross-product term for follow-up with coffee consumption.
See this image and copyright information in PMC

Comment in

  • Coffee drinking and mortality.
    Aberegg SK. Aberegg SK. N Engl J Med. 2012 Aug 9;367(6):575; author reply 576-7. doi: 10.1056/NEJMc1207172. N Engl J Med. 2012. PMID: 22873544 No abstract available.
  • Coffee drinking and mortality.
    Saloustros E, Stratakis CA. Saloustros E, et al. N Engl J Med. 2012 Aug 9;367(6):575-6; author reply 576-7. doi: 10.1056/NEJMc1207172. N Engl J Med. 2012. PMID: 22873545 No abstract available.
  • Coffee drinking and mortality.
    Aubin HJ, Berlin I. Aubin HJ, et al. N Engl J Med. 2012 Aug 9;367(6):576; author reply 576-7. doi: 10.1056/NEJMc1207172. N Engl J Med. 2012. PMID: 22873546 No abstract available.
  • Long-term coffee consumption associated with reduced risk of total and cause-specific mortality.
    Lopez-Garcia E. Lopez-Garcia E. Evid Based Med. 2013 Jun;18(3):116-7. doi: 10.1136/eb-2012-100878. Epub 2012 Aug 25. Evid Based Med. 2013. PMID: 22923704 No abstract available.
  • [Journal club].
    Püllen R, Dovjak P. Püllen R, et al. Z Gerontol Geriatr. 2012 Oct;45(7):673-4. doi: 10.1007/s00391-012-0378-3. Z Gerontol Geriatr. 2012. PMID: 23052284 German. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gómez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007;55:6962–9. [Erratum, J Agric Food Chem 2007;55:8284.] - PubMed
    1. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84:888–93. - PubMed
    1. Arion WJ, Canfield WK, Ramos FC, et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys. 1997;339:315–22. - PubMed
    1. Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009;169:2053–63. - PubMed
    1. Coffee drinking and acute myocardial infarction: report from the Boston Collaborative Drug Surveillance Program. Lancet. 1972;2:1278–81. - PubMed

Publication types

LinkOut - more resources